Drug intelligence / Profile preview

curcuma longa + zingiber officinale + ocimum sanctum

Development stage
Unknown
Lead developer
Composite Interceptive Med Science
Modality
Small Molecules
Administration
Oral
01

Overview

This polyherbal formulation, developed by Composite Interceptive Med Science, is a combination of *Curcuma longa* (turmeric), *Zingiber officinale* (ginger), and *Ocimum sanctum* (tulsi/holy basil). It is primarily being evaluated for the management of frailty in the elderly population. The formulation leverages the synergistic effects of its botanical constituents: curcuminoids from turmeric provide potent anti-inflammatory and antioxidant properties by inhibiting pro-inflammatory cytokines and enzymes; gingerols and shogaols from ginger contribute additional anti-inflammatory and gastroprotective benefits; and tulsi acts as an adaptogen to enhance stress resilience and immune function. In clinical trial settings, the formulation is typically administered orally, often mixed with milk to improve palatability and potentially enhance the absorption of lipophilic compounds like curcumin.

Other names
Turmeric and Tulsi Polyherbal FormulationC. longa + Z. officinale + O. sanctum
02

Targets

NF-κBALOX5 (Arachidonate 5-lipoxygenase)

Beyond the preview

Go deeper on curcuma longa + zingiber officinale + ocimum sanctum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on curcuma longa + zingiber officinale + ocimum sanctum.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call